In HF, with or without PAD, dapagliflozin reduced a composite of worsening HF or CV death and did not increase amputations
-
Published:2023-09
Issue:9
Volume:176
Page:JC99
-
ISSN:0003-4819
-
Container-title:Annals of Internal Medicine
-
language:en
-
Short-container-title:Ann Intern Med
Affiliation:
1. Texas Tech University Health Sciences Center at El Paso, El Paso, Texas, USA (D.M.)
Publisher
American College of Physicians
Subject
General Medicine,Internal Medicine